ETF Holdings Breakdown of CORT

News associated with CORT

Oppenheimer & Co. Inc. Boosts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Oppenheimer & Co. Inc. grew its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 39.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,246 shares of the biotechnology company’s stock after buying an additional 6,246 shares during […] - 2025-06-27 08:36:54

Envestnet Portfolio Solutions Inc. Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Envestnet Portfolio Solutions Inc. bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 5,074 shares of the biotechnology company’s stock, valued at approximately $580,000. Several other institutional investors and hedge funds also recently […] - 2025-06-27 07:37:02

Corcept Therapeutics Incorporated (NASDAQ:CORT) Stock Position Decreased by Blue Trust Inc.

Blue Trust Inc. cut its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 20.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,345 shares of the biotechnology company’s stock after selling 585 shares during the quarter. Blue Trust Inc.’s holdings in Corcept Therapeutics were worth $268,000 at the end of […] - 2025-06-24 08:03:03

Park Avenue Securities LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Park Avenue Securities LLC acquired a new position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 2,266 shares of the biotechnology company’s stock, valued at approximately $259,000. Other large investors have also made changes to their positions in the company. Vanguard Group Inc. […] - 2025-06-16 07:40:48

Pallas Capital Advisors LLC Purchases Shares of 4,014 Corcept Therapeutics Incorporated (NASDAQ:CORT)

Pallas Capital Advisors LLC acquired a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,014 shares of the biotechnology company’s stock, valued at approximately $458,000. Several other hedge funds also recently modified their […] - 2025-06-13 07:59:04

Wellington Management Group LLP Sells 3,347 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

Wellington Management Group LLP cut its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 8.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,719 shares of the biotechnology company’s stock after selling 3,347 shares during the quarter. Wellington Management […] - 2025-06-06 08:04:55

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 4.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 46,033 shares of the biotechnology company’s stock after acquiring an additional 1,790 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Corcept Therapeutics were […] - 2025-05-22 09:30:47

Deutsche Bank AG Purchases 24,051 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

Deutsche Bank AG boosted its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 48.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,600 shares of the biotechnology company’s stock after purchasing an additional 24,051 shares […] - 2025-05-21 07:52:49

Corcept Therapeutics (NASDAQ:CORT) and Kaya (OTCMKTS:KAYS) Critical Comparison

Kaya (OTCMKTS:KAYS – Get Free Report) and Corcept Therapeutics (NASDAQ:CORT – Get Free Report) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, profitability, risk and earnings. Profitability This table compares Kaya and Corcept Therapeutics’ […] - 2025-05-20 06:08:57

Balyasny Asset Management L.P. Has $478,000 Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Balyasny Asset Management L.P. decreased its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 27.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,480 shares of the biotechnology company’s stock after selling 3,515 shares during the quarter. Balyasny Asset […] - 2025-05-16 08:58:48

BNP Paribas Financial Markets Sells 42,258 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

BNP Paribas Financial Markets decreased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 42.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 57,830 shares of the biotechnology company’s stock after selling 42,258 shares during the quarter. BNP Paribas Financial Markets’ holdings […] - 2025-05-16 08:09:00

Corcept Therapeutics (NASDAQ:CORT) Shares Gap Down Following Insider Selling

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report)’s share price gapped down prior to trading on Tuesday following insider selling activity. The stock had previously closed at $73.94, but opened at $67.24. Corcept Therapeutics shares last traded at $69.77, with a volume of 278,894 shares traded. Specifically, CEO Joseph K. Belanoff sold 40,000 shares of […] - 2025-05-08 05:25:24

Notable ETF Inflow Detected - VTWO, INSM, FTAI, CORT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 2000 (Symbol: VTWO) where we have detected an approximate $654.2 million dollar inflow -- that's a 6.1% increase week over week in o - 2025-05-07 14:54:13

Price T Rowe Associates Inc. MD Boosts Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Price T Rowe Associates Inc. MD increased its position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 54,753 shares of the biotechnology company’s stock after acquiring an additional 1,825 shares during […] - 2025-05-07 09:54:45

Mariner LLC Has $673,000 Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Mariner LLC increased its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 13.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 13,362 shares of the biotechnology company’s stock after buying an additional 1,601 shares during the period. Mariner LLC’s holdings in Corcept Therapeutics were worth $673,000 as of its most […] - 2025-04-30 08:19:08

Envestnet Asset Management Inc. Has $1.47 Million Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Envestnet Asset Management Inc. reduced its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 14.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 29,157 shares of the biotechnology company’s stock after selling 5,030 shares during the quarter. Envestnet Asset […] - 2025-04-30 07:42:59

IJR, COOP, EAT, CORT: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Small-Cap ETF (Symbol: IJR) where we have detected an approximate $245.6 million dollar outflow -- that's a 0.3% decrease week - 2025-04-21 14:53:38

Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Invesco Ltd.

Invesco Ltd. lessened its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 17.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 706,133 shares of the biotechnology company’s stock after selling 151,225 shares during the quarter. Invesco Ltd.’s holdings in Corcept Therapeutics were worth $35,582,000 at the end of the most recent […] - 2025-04-17 08:47:00

Federated Hermes Inc. Boosts Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Federated Hermes Inc. raised its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 107.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,870 shares of the biotechnology company’s stock after acquiring an additional 7,172 shares during the period. […] - 2025-04-17 08:09:09

National Bank of Canada FI Purchases New Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT)

National Bank of Canada FI acquired a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 834 shares of the biotechnology company’s stock, valued at approximately $42,000. Other large investors have also recently made changes to their positions in the company. Stifel Financial […] - 2025-04-13 08:44:55

CIBC Private Wealth Group LLC Has $26,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

CIBC Private Wealth Group LLC reduced its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 38.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 512 shares of the biotechnology company’s stock after selling 323 shares during […] - 2025-04-10 09:30:52

Pictet Asset Management Holding SA Increases Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Pictet Asset Management Holding SA grew its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 13.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,538 shares of the biotechnology company’s stock after buying an additional 1,639 shares during […] - 2025-04-08 07:54:59

Canaccord Genuity Group Increases Corcept Therapeutics (NASDAQ:CORT) Price Target to $142.00

Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price objective hoisted by analysts at Canaccord Genuity Group from $130.00 to $142.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price target points to a potential upside of […] - 2025-04-03 07:40:56

Corcept Therapeutics (NASDAQ:CORT) & Biostar Pharmaceuticals (OTCMKTS:BSPM) Head-To-Head Survey

Corcept Therapeutics (NASDAQ:CORT – Get Free Report) and Biostar Pharmaceuticals (OTCMKTS:BSPM – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Volatility & Risk Corcept Therapeutics has a beta […] - 2025-04-03 06:08:59

Corebridge Financial Inc. Has $2.19 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Corebridge Financial Inc. trimmed its holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 7.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,488 shares of the biotechnology company’s stock after selling 3,401 shares during the quarter. Corebridge Financial Inc.’s holdings in Corcept […] - 2025-04-02 10:04:53

Sei Investments Co. Purchases 54,521 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

Sei Investments Co. increased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 120.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,943 shares of the biotechnology company’s stock after acquiring an additional 54,521 shares […] - 2025-04-02 07:56:52

Corcept Therapeutics (NASDAQ:CORT) Price Target Raised to $150.00

Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price target hoisted by stock analysts at HC Wainwright from $115.00 to $150.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 63.17% from the […] - 2025-04-02 05:54:53

Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up Following Analyst Upgrade

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) shares gapped up before the market opened on Monday after Canaccord Genuity Group raised their price target on the stock from $130.00 to $142.00. The stock had previously closed at $54.63, but opened at $94.93. Canaccord Genuity Group currently has a buy rating on the stock. Corcept […] - 2025-04-02 05:12:47

Corcept Therapeutics Reaches Analyst Target Price

In recent trading, shares of Corcept Therapeutics Inc (Symbol: CORT) have crossed above the average analyst 12-month target price of $99.75, changing hands for $114.22/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra - 2025-04-01 11:03:39

Prudential Financial Inc. Lowers Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Prudential Financial Inc. decreased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 95,659 shares of the biotechnology company’s stock after selling 2,483 shares during the quarter. […] - 2025-04-01 08:32:48

CORT institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	59,685	USD 4,436,386
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	24,400	USD 1,813,652
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	867	USD 64,444
Total =		84,952	USD 6,314,482

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer